 | | Vol. 14.33 – 25 August, 2022 |
| |
|
|
| Researchers applied exosome derived from human umbilical cord MSCs and engineered them exogenously with a cyclic peptide, arginine-glycine-aspartate to encapsulate triptolide to establish a bionic-targeted drug delivery system, achieving synergism and toxicity reduction.
[Journal of Nanobiotechnology] |
|
|
|
 | | PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| The authors compared the characteristics and outcomes of andomized clinical trial (RCT) participants to a Francophone population-based registry of patients fulfilling the eligibility criteria used in their RCT and transplanted with one or two umbilical cord blood units after a myeloablative conditioning regimen.
[Transplantation and Cellular Therapy] |
|
|
|
| Scientists identified 136 patients aged between 16 and 69 years who received HLA-haploidentical stem cell transplantation using post-transplant cyclophosphamide as their first transplantation for acute leukemia or myelodysplastic syndromes.
[Bone Marrow Transplantation] |
|
|
|
| The authors investigated the effects of HTR-8/SVneo trophoblasts cell line on macrophage human monocyte cell line polarization and granulocyte colony-stimulating factor secretion, and also analyzed the effects of THP-1 cells on primary trophoblasts and HTR-8 proliferation, invasion, and adhesion.
[American Journal of Reproductive Immunology] |
|
|
|
| Researchers investigated the role of the angiogenic and angiostatic chemokines in placenta and decidua tissues from spontaneous and induced abortions.
[Archives of Gynecology and Obstetrics] |
|
|
|
| Investigators explored a range of polycations, using transduction protocols with and without spinoculation, to produce stably transduced MSCs from derived from umbilical cord, bone marrow, and adipose tissue.
[Molecular Biotechnology].
[Molecular Biotechnology] |
|  |
|
|
|
| Scientists summarize the current understanding of molecular mechanisms that contribute to cell immortalisation, the strategies that have been employed to immortalise amnion-derived cell types, and their likely applications in regenerative medicine.
[Cell Biology International] |
|
|
|
|
| Amniotics AB announced that several batches of PulmoStem™ have been certified by the company’s qualified person and that clinical sites in the UK and Sweden are set to start the enrollment of subjects in the first-in-human Phase I/II study of hospitalized COVID-19 patients.
[Amniotics AB] |
|
|
|
|
| November 1- 6
Orlando, Fforida, United States
|
|
|
|
|
|
| | Harvard Stem Cell Institute – Boston, Massachusetts, United States |
|
|
|
| | STEMCELL Technologies, Inc. – Vancouver, British Columbia, Canada |
|
|
|
| | Oklahoma Medical Research Foundation – Oklahoma City, Oklahoma, United States |
|
|
|
| | Shenzhen Institute of Advanced Technology – Shenzhen, China |
|
|
|
| | Harvard Stem Cell Institute – Boston, Massachusetts, United States |
|
|
|
|
Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News
